Personalized medicine in Parkinson's disease: Time to be precise

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study

(2016) Mario Masellis et al.   BRAIN

Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission

(2016) Qi Qin et al.   CNS Neuroscience & Therapeutics

Advances in understanding genomic markers and pharmacogenetics of Parkinson’s disease

(2016) Félix Javier Jiménez-Jiménez et al.   Expert Opinion on Drug Metabolism & Toxicology

How close are we to individualized medicine for Parkinson’s disease?

(2016) Hee Jin Kim et al.   Expert Review of Neurotherapeutics

Parkinson’s: a syndrome rather than a disease?

(2016) Nataliya Titova et al.   JOURNAL OF NEURAL TRANSMISSION

Nonmotor features of Parkinson's disease subtypes

(2016) Connie Marras et al.   MOVEMENT DISORDERS

Non motor subtypes and Parkinson's disease

(2016) Anna Sauerbier et al.   PARKINSONISM & RELATED DISORDERS

How close are we to individualized medicine for Parkinson’s disease?

(2016) Hee Jin Kim et al.   Expert Review of Neurotherapeutics

Neuropathobiology of non-motor symptoms in Parkinson disease

(2015) Kurt A. Jellinger   JOURNAL OF NEURAL TRANSMISSION

Biomarkers of Parkinson’s disease: Present and future

(2015) Diane B. Miller et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

GBAVariants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

(2015) Ignacio F. Mata et al.   MOVEMENT DISORDERS

Parkinson's disease and narcolepsy-like symptoms

(2015) Ari Ylikoski et al.   SLEEP MEDICINE

Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET

(2014) Trine Gjerløff et al.   BRAIN

Pharmacogenetics of drug response in Parkinson's disease

(2014) Eleonora Džoljić et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Parkinson's disease pharmacogenomics: new findings and perspectives

(2014) Artur F Schumacher-Schuh et al.   PHARMACOGENOMICS

The Heterogeneity of Early Parkinson’s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients

(2013) Roberto Erro et al.   PLoS One

Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease: Fig. 1.

(2013) Anthony H. V. Schapira et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies

(2013) S. Pablo Sardi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impulse control disorders in Parkinson’ disease: the role of personality and cognitive status

(2012) Michele Poletti et al.   JOURNAL OF NEUROLOGY

Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis

(2011) E. Cereda et al.   DIABETES CARE

[18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease

(2011) N. Pavese et al.   NEUROIMAGE

Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson’s disease

(2011) Jee-Young Lee et al.   PARKINSONISM & RELATED DISORDERS

Impulse Control Disorders in Parkinson Disease

(2010) Daniel Weintraub et al.   ARCHIVES OF NEUROLOGY

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction

(2010) N. Pavese et al.   BRAIN

Importance of 123I-Metaiodobenzylguanidine Scintigraphy/Single Photon Emission Computed Tomography for Diagnosis and Differential Diagnostics of Parkinson Syndromes

(2010) Wolfgang H. Jost et al.   Neurodegenerative Diseases

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

(2009) Caroline H. Williams-Gray et al.   BRAIN

Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease

(2009) Jee-Young Lee et al.   MOVEMENT DISORDERS

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET

(2009) H. Shimada et al.   NEUROLOGY

Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight

(2008) J. C. Sharma et al.   EUROPEAN JOURNAL OF NEUROLOGY